Search

everythinglearnresearchcommunity

for

Search:↓

Lupus patients in Ghana face healthcare challenges, and the Oyemam Autoimmune Foundation is working to improve awareness and support.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

Purpura fulminans can signal underlying autoimmune disorders, not just infections.

Antiphospholipid syndrome can severely damage adrenal glands, requiring early diagnosis and treatment.

Bullous lupus can cause severe esophageal issues but responds well to corticosteroids and azathioprine.

Anti-CD19 therapy may help treat SLE and NMOSD.

Atypical symptoms in lupus can indicate different kidney issues.

Early recognition and management of gastrointestinal tuberculosis in lupus patients are crucial to prevent complications.

Correct diagnosis is crucial for treating overlapping conditions like NMOSD and SLE effectively.

Catatonia can be a rare sign of lupus, needing careful diagnosis and treatment.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Clinical signs don't match inflammation levels in lichen planopilaris and frontal fibrosing alopecia.

Kv1.3 blockers may help treat alopecia areata and promote hair regrowth.

Targeting regulatory T cells may help treat age-related diseases.

Higher activity in lichen planopilaris is linked to certain immune and tissue genes.

Women with PCOS may have a reduced ability to fight breast tumor cells over time.

The combined treatment improved scalp health in women with early-stage hair loss.

A girl's hair loss was found to be caused by both a hair-pulling disorder and another hair loss condition.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Diagnosing mycosis fungoides, a rare skin cancer, is difficult in elderly adults and requires careful examination to avoid mistaking it for less serious skin conditions.

Lymphoma should be considered in unusual scalp hair loss cases, as treatment can work but may lead to severe complications.

Repeated biopsies are crucial for managing lupus panniculitis when initial treatments fail.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Potential therapeutic targets for scarring hair loss are identified.

NK cells play a role in skin diseases like eczema and psoriasis.

Certain gut bacteria may protect against hair loss, while others may increase the risk.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.